1Department of Neurology, Laboratory for Neurotherapeutics, Biomedical Research Institute, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul, 110-744 South Korea.
5Department of Neurosurgery, Seoul National University Hospital, Seoul, South Korea.
Antimicrob Resist Infect Control. 2019 Feb 1;8:25. doi: 10.1186/s13756-019-0475-9. eCollection 2019.
Bed-ridden state, dysphagia, altered mental state, or respiratory muscle weakness are common in neurologic patients and increase the risk of pneumonia. The major causes of pneumonia in neurologic patients may differ from those in the general population, resulting in a different pathogen distribution. We investigated the trends of pathogen distribution in culture-positive pneumonia in hospitalized neurologic patients and the related antibiotic resistance in those with hospital-acquired pneumonia (HAP).
A retrospective study was performed at Seoul National University Hospital, South Korea. Patients admitted to the Department of Neurology with a positive respiratory specimen culture between 2007 and 2016 were included. Pneumonia events in patients were screened by chronologically associating the date of respiratory specimen acquisition for culture studies and the date of antibiotics administration. Subgroup analyses regarding multidrug resistance in HAP were performed in different pneumonia categories, by presence of ≥1 risk factor and by time period (first half vs. second half of study period). Microbial resistance profiles of isolates from patients with pneumonia were analyzed.
We identified 351 pneumonia cases in 227 patients involving 36 different pathogens. 232 cases were HAP, of which 70 cases were intensive care unit (ICU)-HAP. The leading pathogens were , , , , and which were isolated in 133 (37.9%), 72 (20.5%), 55 (15.7%), 44 (12.5%), 33 (9.4%), and 27 (7.7%) cases, respectively. Cases with HAP showed a higher proportion of and a lower proportion of (both, < 0.05) than those with non-HAP. ICU-HAP isolates showed a higher multidrug resistance (MDR) rate than non-ICU-HAP isolates ( < 0.005) in those with ≥1 MDR risk factor. Non-susceptibility to imipenem ( < 0.0005), piperacillin-tazobactam ( < 0.001), cefepime ( < 0.005), and trimethoprim-sulfamethoxazole ( < 0.05) in Gram-negative pathogens increased over time in both ICU and non-ICU settings.
, , , , and were the leading isolates in culture-positive pneumonia in hospitalized neurologic patients. Antimicrobial resistance of Gram-negative pathogens in neurologic patients with culture-positive HAP has recently increased.
卧床状态、吞咽困难、神志改变或呼吸肌无力在神经科患者中较为常见,增加了肺炎的风险。神经科患者肺炎的主要病因可能与普通人群不同,导致病原体分布也有所不同。我们研究了培养阳性肺炎患者中病原体分布的趋势以及医院获得性肺炎(HAP)患者的相关抗生素耐药性。
本研究为韩国首尔国立大学医院的一项回顾性研究。纳入 2007 年至 2016 年间因呼吸道标本培养阳性而入住神经内科的患者。通过按时间顺序关联呼吸道标本采集日期和抗生素使用日期,筛查患者的肺炎事件。根据有无≥1 个危险因素和研究期间的时间段(前半段 vs. 后半段),对不同肺炎类别和 HAP 进行了多重耐药的亚组分析。分析了肺炎患者分离株的微生物耐药谱。
我们共确定了 227 例患者中的 351 例肺炎病例,涉及 36 种不同的病原体。232 例为 HAP,其中 70 例为 ICU-HAP。主要病原体为 、 、 、 、 ,分别在 133 例(37.9%)、72 例(20.5%)、55 例(15.7%)、44 例(12.5%)、33 例(9.4%)和 27 例(7.7%)患者中分离到。HAP 病例中 、 的比例较高,而非 HAP 病例中 、 的比例较低(均<0.05)。≥1 个 MDR 危险因素的 ICU-HAP 分离株的多重耐药(MDR)率高于非 ICU-HAP 分离株(<0.005)。在 ICU 和非 ICU 环境中,革兰氏阴性病原体对亚胺培南(<0.0005)、哌拉西林-他唑巴坦(<0.001)、头孢吡肟(<0.005)和复方磺胺甲噁唑(<0.05)的不敏感性均随时间推移而增加。
、 、 、 、 和 是住院神经科患者培养阳性肺炎的主要分离株。神经科 HAP 患者培养阳性革兰氏阴性病原体的抗菌药物耐药性最近有所增加。